Abstract Background: Adequate bowel preparation is crucial for high-quality colonoscopy; however, assessing preparation adequacy can be burdensome for both healthcare providers and patients. In this study, we aimed to develop artificial intelligence (AI) models for the automated identification of bowel PREParation for colonoscopy (AI-PREPOO). Methods: On the day of colonoscopy, participants were instructed to use smartphones to photograph their stool in the toilet after each bowel movement following initiation of polyethylene glycol solution and upload the images to a secure web server. All images were labeled as “ready” or “not ready” for colonoscopy based on clarity and the absence of solid content.…
Author: Rutali Thakur
Artificial intelligence (AI) is reshaping perioperative care, but its value depends on measurable improvements in outcomes and resource use. Dr Andreas Weinberger Rosen and Professor Ismail Gögenur describe how an AI-supported decision system for colorectal cancer surgery can reduce complications, improve quality of life and serve as a blueprint for teams adopting AI-supported precision medicine. Artificial intelligence (AI) has broad potential to transform healthcare systems by automating tasks that require human cognition, such as supporting documentation,1 analysing biopsies2 and planning surgical resources.3 Its value, however, depends on whether this automation can translate into tangible benefits for patient outcomes or more effective use of resources. For…
Abstract Previously, colorectal polyp computer-aided detection (CADe) systems required on-site high-performance hardware installations (e.g., FPGAs/GPUs), creating practical challenges to upgrades and tying hospitals to legacy hardware. Cloud-based CADe solutions overcome these constraints. Hospitals can use low-specification/low-cost hardware to stream data to the cloud for analysis, enabling frequent AI hardware and algorithm updates. Furthermore, existing CADe systems’ benefits are largely limited to smaller, less clinically relevant polyps ( < 10 mm). This parallel-group RCT evaluated a real-time cloud-deployed CADe-system trained on an enhanced dataset of clinically significant polyps (large polyps( ≥ 10 mm) and sessile-serrated-lesions(SSLs)). Patients from eight centers across four European countries (841 patients, 22 endoscopists)…
SAGA Diagnostics has launched its ultrasensitive Pathlight™ MRD test for colorectal cancer, extending a platform already in use for early-stage breast cancer into GI oncology. Backed by data from one of the largest real-world ctDNA studies in stage I–III CRC, the test is designed to detect molecular residual disease at levels conventional assays miss. What’s striking is when Pathlight flags risk. In the CITCCA cohort, more than 40% of high-risk patients harbored residual disease at a key clinical landmark — detectable only at ultra-low ctDNA levels. Those signals weren’t academic: ctDNA status strongly separated patients with high versus low relapse…
According to Becker’s ASC Review, gastroenterology is heading into 2026 facing major disruption as rising demand collides with operational and financial pressure. Earlier-onset GI cancers are expanding the screening population, driving sustained growth in colonoscopy and endoscopy volumes while increasing case complexity. Practices are managing sicker, higher-acuity patients and greater chronic disease burden, even as staffing shortages persist. Becker’s highlights AI-enabled patient access and automation as essential tools to absorb demand, while procedures continue shifting from hospitals to ASCs. At the same time, tighter reimbursement and evolving payer expectations are forcing GI groups to rethink site-of-care strategy, value-based alignment, and…
Doctronic AI, the AI-native health platform delivering fast, private, and personalized healthcare at scale, today announced the appointment of Byron Crowe, MD, MSc as Chief Medical Officer (CMO). In this role, Dr. Crowe will lead Doctronic’s clinical strategy and product innovation efforts while expanding the company’s affiliated nationwide physician practice. In addition to his industry leadership, Dr. Crowe is an accomplished academic clinician, most recently serving on the faculty at Harvard Medical School and as a practicing physician at Beth Israel Deaconess Medical Center. His research focused on evaluating large language model–based AI systems in complex diagnosis and clinical reasoning,…
If you knew your next decision could change your career, your wealth, and the direction of an entire field—would you make it?In November 2021, before teaching blockchain and crypto in my first GI Mastermind, I made my first Bitcoin investment. I wanted to act, not theorize.That mindset—acting before it’s obvious—changed everything.My Bitcoin is up 347%, Ethereum 140%, U.S. stocks 47% since March.Not luck. Direction.That same clarity reshaped NextServices from a billing company into an AI-first organization.We built automations, explored AI, and partnered with 100ms to bring AI voice agents into GI. This technology is about to redefine how the industry works.It’s the same conviction behind my books Scope Forward and The Shift, my Presidential Plenary at…
Gastroenterologists see steady pay growth as they advance in their careers, according to salary data from Marit Health, which collects anonymous physician compensation information. Here’s how workload and pay compare across experience levels: 0-2 years of experience Average workload: 46 hours a week Average annual compensation: $553,000 3-5 years of experience Average workload: 49 hours a week Average annual compensation: $555,000
Gastroenterology is being squeezed from both sides. On one side, staffing shortages are worsening. By 2025, the U.S. will face a deficit of more than 1,600 full-time gastroenterologists. Half of today’s GIs are already over 55. Meanwhile, private practices are drowning in rising labor costs—92% saw year-over-year expense hikes in 2024 alone. On the other side, the traditional business model is breaking down. Colonoscopy reimbursements have declined 40–50% in real dollar terms over the past 25 years. Practices tied to fee-for-service payments are watching margins erode while expenses climb. The old playbook will not carry us through. Now zoom out.…
The gastroenterology industry keeps talking about AI for endoscopies and polyp detection. Useful, yes. But it’s also like trying to bolt wheels onto a horse buggy. That’s what industries tried when Ford launched the car—optimize the buggy instead of building highways. GI’s motor car has already arrived. Today, startups peg the GI industry at $136 billion across the spectrum—IBD, IBS, obesity, liver disease, microbiome, motility, CRC, digital health. Digitization doesn’t grow industries by 10%. It grows them by 10x. That puts GI on the path to $1+ trillion. Look at history: AI gives us the same opportunity in GI. Not…
